India has banned the over-the-counter sale of cough syrups and other syrup medicines, requiring a doctor's prescription for all purchases [1, 2].
This regulatory shift aims to prevent the misuse of pharmaceutical products and combat addiction to specific ingredients. By restricting access, the government intends to protect public health and reduce the prevalence of self-medication with potentially dangerous substances [1, 2].
The Union Ministry of Health and Family Welfare implemented the change by amending the Drugs Rules, 1945 [1, 2]. These amendments make the prescription requirement effective immediately across the country [1, 2].
Officials specifically targeted syrups containing codeine, which are frequently subject to misuse [1, 2]. The move is designed to ensure that these medications are administered only under professional medical supervision to avoid the risks associated with dependency [1, 2].
Medical professionals have responded positively to the new mandate. Doctors said the tough stance by the center could save lives by limiting the availability of addictive syrups to those with legitimate medical needs [2].
The restriction applies to a broad range of syrup-based medicines, not just those used for coughs [1, 2]. This comprehensive approach ensures that various syrup formulations cannot be easily obtained without a valid medical consultation [1, 2].
“India has banned the over-the-counter sale of cough syrups”
This policy shift represents a significant tightening of pharmaceutical controls in India. By moving cough syrups from the over-the-counter category to prescription-only, the government is prioritizing the prevention of substance abuse over consumer convenience. This move likely targets the systemic misuse of codeine-based products and aligns India's pharmaceutical regulations more closely with international standards for controlled substances.
